Supportive and symptomatic management of amyotrophic lateral sclerosis

  title={Supportive and symptomatic management of amyotrophic lateral sclerosis},
  author={Esther V Hobson and C. Mcdermott},
  journal={Nature Reviews Neurology},
  • Esther V Hobson, C. Mcdermott
  • Published 2016
  • Medicine
  • Nature Reviews Neurology
  • The main aims in the care of individuals with amyotrophic lateral sclerosis (ALS) are to minimize morbidity and maximize quality of life. Although no cure exists for ALS, supportive and symptomatic care provided by a specialist multidisciplinary team can improve survival. The basis for supportive management is shifting from expert consensus guidelines towards an evidence-based approach, which encourages the use of effective treatments and could reduce the risk of harm caused by ineffective or… CONTINUE READING
    47 Citations

    Figures, Tables, and Topics from this paper.

    Costs of illness in amyotrophic lateral sclerosis (ALS): a cross-sectional survey in Germany
    • 1
    Palliative medicine and end-of-life care.
    Symptomatic pharmacotherapy in ALS: data analysis from a platform-based medication management programme
    • 2
    • PDF
    Triage of Amyotrophic Lateral Sclerosis Patients during the COVID-19 Pandemic: An Application of the D50 Model


    Is There a Role for Exercise in the Management of Bulbar Dysfunction in Amyotrophic Lateral Sclerosis?
    • E. Plowman
    • Psychology, Medicine
    • Journal of speech, language, and hearing research : JSLHR
    • 2015
    • 20
    • PDF
    Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
    • 247
    A multidisciplinary clinic approach improves survival in ALS: a comparative study of ALS in Ireland and Northern Ireland
    • 111
    • PDF